CA
BBIO icon

CoreCap Advisors’s BridgeBio Pharma BBIO Stock Holding History

CoreCap Advisors’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$74.5K Hold
1,000
– – ﹤0.01% 1237
2026
Q1 		$74.3K Hold
1,000
– – ﹤0.01% 1147
2025
Q4 		$76.5K Hold
1,000
– – ﹤0.01% 1138
2025
Q3 		$51.9K Hold
1,000
– – ﹤0.01% 1314
2025
Q2 		$43.2K Buy
+1,000
New +$36.4K ﹤0.01% 1314

Other funds holding BBIO

TE
Tema ETFs New York $3.09B AUM 72.72% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $77B AUM 50.57% 1-Year Est. Return
FBT
First Bank & Trust Brookings, South Dakota $680M AUM 25.36% 1-Year Est. Return
CPBTD
Central Pacific Bank - Trust Division Honolulu, Hawaii $984M AUM 34.19% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $19.6B AUM 18.11% 1-Year Est. Return
WP
Westmount Partners Los Angeles, California $454M AUM 31.05% 1-Year Est. Return
PR
PSP Research Newtown Square, Pennsylvania $188M AUM
HIA
Harbor Investment Advisory Lutherville, Maryland $1.43B AUM 30.71% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return